Enhancing integrin function by VEGF/neuropilin signaling

References

• Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell 2002; 110:673 - 87; http://dx.doi.org/10.1016/S0092-8674(02)00971-6; PMID: 12297042
   PubMed Web of Science ®Google Scholar
• Kim C, Ye F, Ginsberg MH. Regulation of integrin activation. Annu Rev Cell Dev Biol 2011; 27:321 - 45; http://dx.doi.org/10.1146/annurev-cellbio-100109-104104; PMID: 21663444
   PubMed Web of Science ®Google Scholar
• Springer TA, Dustin ML. Integrin inside-out signaling and the immunological synapse. Curr Opin Cell Biol 2012; 24:107 - 15; http://dx.doi.org/10.1016/j.ceb.2011.10.004; PMID: 22129583
   PubMed Web of Science ®Google Scholar
• Carman CV, Springer TA. Integrin avidity regulation: are changes in affinity and conformation underemphasized?. Curr Opin Cell Biol 2003; 15:547 - 56; http://dx.doi.org/10.1016/j.ceb.2003.08.003; PMID: 14519389
   PubMed Web of Science ®Google Scholar
• Margadant C, Monsuur HN, Norman JC, Sonnenberg A. Mechanisms of integrin activation and trafficking. Curr Opin Cell Biol 2011; 23:607 - 14; http://dx.doi.org/10.1016/j.ceb.2011.08.005; PMID: 21924601
   PubMed Web of Science ®Google Scholar
• Ivaska J, Heino J. Cooperation between integrins and growth factor receptors in signaling and endocytosis. Annu Rev Cell Dev Biol 2011; 27:291 - 320; http://dx.doi.org/10.1146/annurev-cellbio-092910-154017; PMID: 21663443
   PubMed Web of Science ®Google Scholar
• Hemler ME. Tetraspanin functions and associated microdomains. Nat Rev Mol Cell Biol 2005; 6:801 - 11; http://dx.doi.org/10.1038/nrm1736; PMID: 16314869
   PubMed Web of Science ®Google Scholar
• Ferrara N. VEGF as a therapeutic target in cancer. Oncology 2005; 69:Suppl 3 11 - 6; http://dx.doi.org/10.1159/000088479; PMID: 16301831
   PubMed Web of Science ®Google Scholar
• Vlahakis NE, Young BA, Atakilit A, Sheppard D. The lymphangiogenic vascular endothelial growth factors VEGF-C and -D are ligands for the integrin alpha9beta1. J Biol Chem 2005; 280:4544 - 52; http://dx.doi.org/10.1074/jbc.M412816200; PMID: 15590642
   PubMed Web of Science ®Google Scholar
• Uniewicz KA, Fernig DG. Neuropilins: a versatile partner of extracellular molecules that regulate development and disease. Front Biosci 2008; 13:4339 - 60; http://dx.doi.org/10.2741/3008; PMID: 18508514
   PubMed Web of Science ®Google Scholar
• Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 1998; 92:735 - 45; http://dx.doi.org/10.1016/S0092-8674(00)81402-6; PMID: 9529250
   PubMed Web of Science ®Google Scholar
• Takahashi T, Fournier A, Nakamura F, Wang LH, Murakami Y, Kalb RG, et al. Plexin-neuropilin-1 complexes form functional semaphorin-3A receptors. Cell 1999; 99:59 - 69; http://dx.doi.org/10.1016/S0092-8674(00)80062-8; PMID: 10520994
   PubMed Web of Science ®Google Scholar
• Nasarre C, Koncina E, Labourdette G, Cremel G, Roussel G, Aunis D, et al. Neuropilin-2 acts as a modulator of Sema3A-dependent glioma cell migration. Cell Adh Migr 2009; 3:383 - 9; http://dx.doi.org/10.4161/cam.3.4.9934; PMID: 19855168
   PubMed Web of Science ®Google Scholar
• Gaur P, Bielenberg DR, Samuel S, Bose D, Zhou Y, Gray MJ, et al. Role of class 3 semaphorins and their receptors in tumor growth and angiogenesis. Clin Cancer Res 2009; 15:6763 - 70; http://dx.doi.org/10.1158/1078-0432.CCR-09-1810; PMID: 19887479
   PubMed Web of Science ®Google Scholar
• Neufeld G, Kessler O, Herzog Y. The interaction of Neuropilin-1 and Neuropilin-2 with tyrosine-kinase receptors for VEGF. Adv Exp Med Biol 2002; 515:81 - 90; http://dx.doi.org/10.1007/978-1-4615-0119-0_7; PMID: 12613545
   PubMed Web of Science ®Google Scholar
• Fukasawa M, Matsushita A, Korc M. Neuropilin-1 interacts with integrin beta1 and modulates pancreatic cancer cell growth, survival and invasion. Cancer Biol Ther 2007; 6:1173 - 80; PMID: 17726369
   PubMed Web of Science ®Google Scholar
• Valdembri D, Caswell PT, Anderson KI, Schwarz JP, König I, Astanina E, et al. Neuropilin-1/GIPC1 signaling regulates alpha5beta1 integrin traffic and function in endothelial cells. PLoS Biol 2009; 7:e25; http://dx.doi.org/10.1371/journal.pbio.1000025; PMID: 19175293
   PubMed Web of Science ®Google Scholar
• Goel HL, Pursell B, Standley C, Fogarty K, Mercurio AM. Neuropilin-2 regulates α6β1 integrin in the formation of focal adhesions and signaling. J Cell Sci 2012; 125:497 - 506; http://dx.doi.org/10.1242/jcs.094433; PMID: 22302985
   PubMed Web of Science ®Google Scholar
• Byzova TV, Goldman CK, Pampori N, Thomas KA, Bett A, Shattil SJ, et al. A mechanism for modulation of cellular responses to VEGF: activation of the integrins. Mol Cell 2000; 6:851 - 60; PMID: 11090623
   PubMed Web of Science ®Google Scholar
• Mahabeleshwar GH, Feng W, Reddy K, Plow EF, Byzova TV. Mechanisms of integrin-vascular endothelial growth factor receptor cross-activation in angiogenesis. Circ Res 2007; 101:570 - 80; http://dx.doi.org/10.1161/CIRCRESAHA.107.155655; PMID: 17641225
   PubMed Web of Science ®Google Scholar
• Serini G, Valdembri D, Zanivan S, Morterra G, Burkhardt C, Caccavari F, et al. Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function. Nature 2003; 424:391 - 7; http://dx.doi.org/10.1038/nature01784; PMID: 12879061
   PubMed Web of Science ®Google Scholar
• Bachelder RE, Lipscomb EA, Lin X, Wendt MA, Chadborn NH, Eickholt BJ, et al. Competing autocrine pathways involving alternative neuropilin-1 ligands regulate chemotaxis of carcinoma cells. Cancer Res 2003; 63:5230 - 3; PMID: 14500350
   PubMed Web of Science ®Google Scholar
• Pan H, Wanami LS, Dissanayake TR, Bachelder RE. Autocrine semaphorin3A stimulates alpha2 beta1 integrin expression/function in breast tumor cells. Breast Cancer Res Treat 2009; 118:197 - 205; http://dx.doi.org/10.1007/s10549-008-0179-y; PMID: 18787945
   PubMed Web of Science ®Google Scholar
• Hervé MA, Buteau-Lozano H, Vassy R, Bieche I, Velasco G, Pla M, et al. Overexpression of vascular endothelial growth factor 189 in breast cancer cells leads to delayed tumor uptake with dilated intratumoral vessels. Am J Pathol 2008; 172:167 - 78; http://dx.doi.org/10.2353/ajpath.2008.070181; PMID: 18079435
   PubMed Web of Science ®Google Scholar
• Vintonenko N, Pelaez-Garavito I, Buteau-Lozano H, Toullec A, Lidereau R, Perret GY, et al. Overexpression of VEGF189 in breast cancer cells induces apoptosis via NRP1 under stress conditions. Cell Adh Migr 2011; 5:332 - 43; http://dx.doi.org/10.4161/cam.5.4.17287; PMID: 21897119
   PubMed Web of Science ®Google Scholar
• Robinson SD, Reynolds LE, Kostourou V, Reynolds AR, da Silva RG, Tavora B, et al. Alphav beta3 integrin limits the contribution of neuropilin-1 to vascular endothelial growth factor-induced angiogenesis. J Biol Chem 2009; 284:33966 - 81; http://dx.doi.org/10.1074/jbc.M109.030700; PMID: 19837659
   PubMed Web of Science ®Google Scholar
• Mercurio AM. Laminin: multiple forms, multiple receptors. Curr Opin Cell Biol 1990; 2:845 - 9; http://dx.doi.org/10.1016/0955-0674(90)90082-P; PMID: 2150589
   PubMed Web of Science ®Google Scholar
• Friedrichs K, Ruiz P, Franke F, Gille I, Terpe HJ, Imhof BA. High expression level of alpha 6 integrin in human breast carcinoma is correlated with reduced survival. Cancer Res 1995; 55:901 - 6; PMID: 7850807
   PubMed Web of Science ®Google Scholar
• Cariati M, Naderi A, Brown JP, Smalley MJ, Pinder SE, Caldas C, et al. Alpha-6 integrin is necessary for the tumourigenicity of a stem cell-like subpopulation within the MCF7 breast cancer cell line. Int J Cancer 2008; 122:298 - 304; http://dx.doi.org/10.1002/ijc.23103; PMID: 17935134
   PubMed Web of Science ®Google Scholar
• Yu KR, Yang SR, Jung JW, Kim H, Ko K, Han DW, et al. CD49f enhances multipotency and maintains stemness through the direct regulation of OCT4 and SOX2. Stem Cells 2012; 30:876 - 87; http://dx.doi.org/10.1002/stem.1052; PMID: 22311737
   PubMed Web of Science ®Google Scholar
• Lathia JD, Gallagher J, Heddleston JM, Wang J, Eyler CE, Macswords J, et al. Integrin alpha 6 regulates glioblastoma stem cells. Cell Stem Cell 2010; 6:421 - 32; http://dx.doi.org/10.1016/j.stem.2010.02.018; PMID: 20452317
   PubMed Web of Science ®Google Scholar
• Mercurio AM, Shaw LM. Macrophage interactions with laminin: PMA selectively induces the adherence and spreading of mouse macrophages on a laminin substratum. J Cell Biol 1988; 107:1873 - 80; http://dx.doi.org/10.1083/jcb.107.5.1873; PMID: 2972733
   PubMed Web of Science ®Google Scholar
• Shaw LM, Mercurio AM. Interferon gamma and lipopolysaccharide promote macrophage adherence to basement membrane glycoproteins. J Exp Med 1989; 169:303 - 8; http://dx.doi.org/10.1084/jem.169.1.303; PMID: 2491881
   PubMed Web of Science ®Google Scholar
• Goel HL, Chang C, Pursell B, Leav I, Lyle S, Xi HS, et al. VEGF/Neuropilin-2 Regulation of Bmi-1 and Consequent Repression of IGF-IR Define a Novel Mechanism of Aggressive Prostate Cancer. Cancer Discov 2012; 2:906 - 21; http://dx.doi.org/10.1158/2159-8290.CD-12-0085; PMID: 22777769
   PubMed Web of Science ®Google Scholar
• Yasuoka H, Kodama R, Tsujimoto M, Yoshidome K, Akamatsu H, Nakahara M, et al. Neuropilin-2 expression in breast cancer: correlation with lymph node metastasis, poor prognosis, and regulation of CXCR4 expression. BMC Cancer 2009; 9:220; http://dx.doi.org/10.1186/1471-2407-9-220; PMID: 19580679
   PubMed Web of Science ®Google Scholar
• Bagri A, Tessier-Lavigne M, Watts RJ. Neuropilins in tumor biology. Clin Cancer Res 2009; 15:1860 - 4; http://dx.doi.org/10.1158/1078-0432.CCR-08-0563; PMID: 19240167
   PubMed Web of Science ®Google Scholar
• Kawasaki T, Kitsukawa T, Bekku Y, Matsuda Y, Sanbo M, Yagi T, et al. A requirement for neuropilin-1 in embryonic vessel formation. Development 1999; 126:4895 - 902; PMID: 10518505
   PubMed Web of Science ®Google Scholar
• Chen H, Bagri A, Zupicich JA, Zou Y, Stoeckli E, Pleasure SJ, et al. Neuropilin-2 regulates the development of selective cranial and sensory nerves and hippocampal mossy fiber projections. Neuron 2000; 25:43 - 56; http://dx.doi.org/10.1016/S0896-6273(00)80870-3; PMID: 10707971
   PubMed Web of Science ®Google Scholar
• Muders MH, Zhang H, Wang E, Tindall DJ, Datta K. Vascular endothelial growth factor-C protects prostate cancer cells from oxidative stress by the activation of mammalian target of rapamycin complex-2 and AKT-1. Cancer Res 2009; 69:6042 - 8; http://dx.doi.org/10.1158/0008-5472.CAN-09-0552; PMID: 19638584
   PubMed Web of Science ®Google Scholar
• Facchinetti V, Ouyang W, Wei H, Soto N, Lazorchak A, Gould C, et al. The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C. EMBO J 2008; 27:1932 - 43; http://dx.doi.org/10.1038/emboj.2008.120; PMID: 18566586
   PubMed Web of Science ®Google Scholar
• Zhang XA, Bontrager AL, Hemler ME. Transmembrane-4 superfamily proteins associate with activated protein kinase C (PKC) and link PKC to specific beta(1) integrins. J Biol Chem 2001; 276:25005 - 13; http://dx.doi.org/10.1074/jbc.M102156200; PMID: 11325968
   PubMed Web of Science ®Google Scholar
• Shaw LM, Messier JM, Mercurio AM. The activation dependent adhesion of macrophages to laminin involves cytoskeletal anchoring and phosphorylation of the alpha 6 beta 1 integrin. J Cell Biol 1990; 110:2167 - 74; http://dx.doi.org/10.1083/jcb.110.6.2167; PMID: 2141029
   PubMed Web of Science ®Google Scholar
• Hamerlik P, Lathia JD, Rasmussen R, Wu Q, Bartkova J, Lee M, et al. Autocrine VEGF-VEGFR2-Neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growth. J Exp Med 2012; 209:507 - 20; http://dx.doi.org/10.1084/jem.20111424; PMID: 22393126
   PubMed Web of Science ®Google Scholar
• Berger P, Ballmer-Hofer K. The reception and the party after: how vascular endothelial growth factor receptor 2 explores cytoplasmic space. Swiss Med Wkly 2011; 141:w13318; PMID: 22180219
   PubMedGoogle Scholar
• Caswell PT, Vadrevu S, Norman JC. Integrins: masters and slaves of endocytic transport. Nat Rev Mol Cell Biol 2009; 10:843 - 53; http://dx.doi.org/10.1038/nrm2799; PMID: 19904298
   PubMed Web of Science ®Google Scholar
• Caunt M, Mak J, Liang WC, Stawicki S, Pan Q, Tong RK, et al. Blocking neuropilin-2 function inhibits tumor cell metastasis. Cancer Cell 2008; 13:331 - 42; http://dx.doi.org/10.1016/j.ccr.2008.01.029; PMID: 18394556
   PubMed Web of Science ®Google Scholar
• Gray MJ, Van Buren G, Dallas NA, Xia L, Wang X, Yang AD, et al. Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver. J Natl Cancer Inst 2008; 100:109 - 20; http://dx.doi.org/10.1093/jnci/djm279; PMID: 18182619
   PubMed Web of Science ®Google Scholar
• Hehlgans S, Haase M, Cordes N. Signalling via integrins: implications for cell survival and anticancer strategies. Biochim Biophys Acta 2007; 1775:163 - 80; PMID: 17084981
   PubMed Web of Science ®Google Scholar
• Millard M, Odde S, Neamati N. Integrin targeted therapeutics. Theranostics 2011; 1:154 - 88; http://dx.doi.org/10.7150/thno/v01p0154; PMID: 21547158
   PubMed Web of Science ®Google Scholar
• Lichtenberger BM, Tan PK, Niederleithner H, Ferrara N, Petzelbauer P, Sibilia M. Autocrine VEGF signaling synergizes with EGFR in tumor cells to promote epithelial cancer development. Cell 2010; 140:268 - 79; http://dx.doi.org/10.1016/j.cell.2009.12.046; PMID: 20141840
   PubMed Web of Science ®Google Scholar
• Beck B, Driessens G, Goossens S, Youssef KK, Kuchnio A, Caauwe A, et al. A vascular niche and a VEGF-Nrp1 loop regulate the initiation and stemness of skin tumours. Nature 2011; 478:399 - 403; http://dx.doi.org/10.1038/nature10525; PMID: 22012397
   PubMed Web of Science ®Google Scholar
• Takano S, Yoshii Y, Kondo S, Suzuki H, Maruno T, Shirai S, et al. Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients. Cancer Res 1996; 56:2185 - 90; PMID: 8616870
   PubMed Web of Science ®Google Scholar
• Mak P, Leav I, Pursell B, Bae D, Yang X, Taglienti CA, et al. ERbeta impedes prostate cancer EMT by destabilizing HIF-1alpha and inhibiting VEGF-mediated snail nuclear localization: implications for Gleason grading. Cancer Cell 2010; 17:319 - 32; http://dx.doi.org/10.1016/j.ccr.2010.02.030; PMID: 20385358
   PubMed Web of Science ®Google Scholar
• Cao Y, Wang L, Nandy D, Zhang Y, Basu A, Radisky D, et al. Neuropilin-1 upholds dedifferentiation and propagation phenotypes of renal cell carcinoma cells by activating Akt and sonic hedgehog axes. Cancer Res 2008; 68:8667 - 72; http://dx.doi.org/10.1158/0008-5472.CAN-08-2614; PMID: 18974107
   PubMed Web of Science ®Google Scholar
• Gleason DF, Mellinger GT. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 1974; 111:58 - 64; PMID: 4813554
   PubMed Web of Science ®Google Scholar
• Bae D, Lu S, Taglienti CA, Mercurio AM. Metabolic stress induces the lysosomal degradation of neuropilin-1 but not neuropilin-2. J Biol Chem 2008; 283:28074 - 80; http://dx.doi.org/10.1074/jbc.M804203200; PMID: 18708346
   PubMed Web of Science ®Google Scholar
• Yaqoob U, Cao S, Shergill U, Jagavelu K, Geng Z, Yin M, et al. Neuropilin-1 stimulates tumor growth by increasing fibronectin fibril assembly in the tumor microenvironment. Cancer Res 2012; 72:4047 - 59; http://dx.doi.org/10.1158/0008-5472.CAN-11-3907; PMID: 22738912
   PubMed Web of Science ®Google Scholar
• Goel HL, Bae D, Pursell B, Gouvin LM, Lu S, Mercurio AM. Neuropilin-2 promotes branching morphogenesis in the mouse mammary gland. Development 2011; 138:2969 - 76; http://dx.doi.org/10.1242/dev.051318; PMID: 21693513
   PubMed Web of Science ®Google Scholar
• Guan JL. Integrin signaling through FAK in the regulation of mammary stem cells and breast cancer. IUBMB Life 2010; 62:268 - 76; PMID: 20101634
   PubMed Web of Science ®Google Scholar
• Lukacs RU, Memarzadeh S, Wu H, Witte ON. Bmi-1 is a crucial regulator of prostate stem cell self-renewal and malignant transformation. Cell Stem Cell 2010; 7:682 - 93; http://dx.doi.org/10.1016/j.stem.2010.11.013; PMID: 21112563
   PubMed Web of Science ®Google Scholar
• Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, Regev A, et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 2008; 40:499 - 507; http://dx.doi.org/10.1038/ng.127; PMID: 18443585
   PubMed Web of Science ®Google Scholar
• Pece S, Tosoni D, Confalonieri S, Mazzarol G, Vecchi M, Ronzoni S, et al. Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content. Cell 2010; 140:62 - 73; http://dx.doi.org/10.1016/j.cell.2009.12.007; PMID: 20074520
   PubMed Web of Science ®Google Scholar